A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers
Clinical trial NCT03411421 · TERMINATED
Trial details
- NCT number
- NCT03411421
- Sponsor
- Alios Biopharma Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-03
- Primary completion
- 2018-04-27
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.